<DOC>
	<DOC>NCT02625545</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of using UroLift in subjects with a prostatic median lobe enlargement due to BPH.</brief_summary>
	<brief_title>Study of Median Lobe Prostatic UroLift Procedure</brief_title>
	<detailed_description>Study Objectives: Evaluate the safety and effectiveness of the UroLiftÂ® System when used in symptomatic benign prostatic hyperplasia (BPH) subjects with an enlarged median lobe. Study Design: Prospective, multicenter, non-blinded, single arm (non-randomized) study. Sample Size: A total of no more than 40 subjects will be enrolled. Subject Population: Males age of 50 years or older diagnosed with lower urinary tract symptoms (LUTS) with enlarged median lobe.</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Enlarged median lobe (ML) contributing to obstruction of the prostate BPH</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>